KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 85 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $811,896 | +8.9% | 84,309 | +1.8% | 0.00% | – |
| Q2 2023 | $745,209 | +14.2% | 82,801 | -0.3% | 0.00% | – |
| Q1 2023 | $652,467 | +16.3% | 83,011 | -0.0% | 0.00% | – |
| Q4 2022 | $561,202 | -53.3% | 83,018 | +0.3% | 0.00% | – |
| Q3 2022 | $1,201,000 | +67.0% | 82,732 | +13.1% | 0.00% | – |
| Q2 2022 | $719,000 | -29.9% | 73,135 | +5.1% | 0.00% | – |
| Q1 2022 | $1,026,000 | +17.9% | 69,570 | +5.8% | 0.00% | – |
| Q4 2021 | $870,000 | -31.9% | 65,732 | -10.2% | 0.00% | – |
| Q3 2021 | $1,278,000 | -37.7% | 73,236 | -14.5% | 0.00% | – |
| Q2 2021 | $2,053,000 | -27.7% | 85,680 | -22.5% | 0.00% | -100.0% |
| Q1 2021 | $2,839,000 | +229.7% | 110,504 | +143.8% | 0.00% | – |
| Q4 2020 | $861,000 | +62.8% | 45,329 | +7.7% | 0.00% | – |
| Q3 2020 | $529,000 | +3.5% | 42,079 | -0.2% | 0.00% | – |
| Q2 2020 | $511,000 | +90.7% | 42,180 | +20.3% | 0.00% | – |
| Q1 2020 | $268,000 | -57.0% | 35,069 | +0.2% | 0.00% | – |
| Q4 2019 | $623,000 | +45.6% | 34,999 | -5.1% | 0.00% | – |
| Q3 2019 | $428,000 | -50.5% | 36,899 | -5.6% | 0.00% | – |
| Q2 2019 | $865,000 | +324.0% | 39,086 | +448.3% | 0.00% | – |
| Q1 2019 | $204,000 | – | 7,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |